psilocybin (SYNP-101) / Ceruvia Lifesci, Yale University - LARVOL DELTA

Psilocybin for the Treatment of Cluster Headache (clinicaltrials.gov) - P1 | N=25 | Completed | Sponsor: Yale University | Active, not recruiting ➔ Completed

Trial completion • Chronic Cluster Headache • CNS Disorders • Migraine • Pain

Psilocybin for the Treatment of Cluster Headache (clinicaltrials.gov) - P1 | N=24 | Active, not recruiting | Sponsor: Yale University | Trial completion date: Jun 2023 ➔ Sep 2023 | Trial primary completion date: Jun 2023 ➔ Jun 2022

Trial completion date • Trial primary completion date • Chronic Cluster Headache • CNS Disorders • Migraine • Pain

Psilocybin for the Treatment of Migraine Headache (clinicaltrials.gov) - P1 | N=14 | Completed | Sponsor: Yale University | Active, not recruiting ➔ Completed | N=24 ➔ 14

Enrollment change • Trial completion • CNS Disorders • Migraine • Pain